*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ James/NNP Andress/NNP ]
,/, 
[ a/DT top/JJ executive/NN ]
at/IN 
[ SmithKline/NNP Beecham/NNP PLC/NNP ]
,/, resigned/VBD unexpectedly/RB in/IN 
[ a/DT sign/NN ]
of/IN growing/VBG 
[ pains/NNS ]
at/IN 
[ the/DT ]
newly/RB merged/VBN 
[ health-care/JJ giant/NN ]
here/RB ./. 

======================================

[ Mr./NNP Andress/NNP ]
,/, 
[ who/WP ]
shared/VBD 
[ the/DT No./NN 3/CD spot/NN ]
at/IN 
[ SmithKline/NNP Beecham/NNP ]
,/, is/VBZ quitting/VBG 
[ his/PRP$ #/# 325,000-a-year/JJ ]
 (/( 
[ $/$ 502,613/CD ]
 )/) 
[ job/NN ]
to/TO run/VB 
[ a/DT much/RB smaller/JJR company/NN ]
outside/IN 
[ the/DT pharmaceutical/JJ industry/NN ]
./. 

[ Next/JJ month/NN ]
,/, 
[ he/PRP ]
becomes/VBZ 
[ president/NN ]
and/CC 
[ chief/JJ operating/VBG officer/NN ]
of/IN 
[ Information/NNP Resources/NNP Inc./NNP ]
,/, 
[ Chicago-based/JJ ]
marketing/NN 
[ consultants/NNS ]
with/IN 
[ $/$ 150/CD million/CD ]
in/IN 
[ annual/JJ sales/NNS ]
./. 

======================================

[ Mr./NNP Andress/NNP ]
gave/VBD up/RP 
[ the/DT presidency/NN ]
of/IN 
[ U.S./NNP drug/NN maker/NN Sterling/NNP Drug/NNP Inc./NNP ]
in/IN 
[ 1988/CD ]
to/TO become/VB 
[ heir/NN ]
apparent/JJ to/TO 
[ then/JJ Beecham/NNP Group/NNP PLC/NNP Chairman/NNP Robert/NNP Bauman/NNP ]
./. 

[ A/DT year/NN ]
later/RBR ,/, 
[ Beecham/NNP ]
merged/VBD with/IN 
[ Philadelphia/NNP 's/POS SmithKline/NNP Beckman/NNP Corp/NNP ]
./. 

======================================

[ John/NNP Chappell/NNP ]
,/, 
[ a/DT senior/JJ SmithKline/NNP executive/NN ]
,/, took/VBD over/RP 
[ Mr./NNP Andress/NNP 's/POS responsibility/NN ]
for/IN 
[ the/DT pharmaceutical/JJ business/NN following/VBG completion/NN ]
of/IN 
[ the/DT unusual/JJ trans-Atlantic/JJ marriage/NN ]
./. 

======================================

[ Mr./NNP Andress/NNP ]
said/VBD 
[ SmithKline/NNP Beecham/NNP ]
will/MD eliminate/VB 
[ his/PRP$ post/NN ]
as/IN 
[ chairman/NN ]
for/IN 
[ health-care/JJ products/NNS ]
and/CC 
[ services/NNS ]
because/IN 
[ he/PRP ]
finished/VBD integrating/VBG 
[ those/DT businesses/NNS ]
./. 

``/`` 
[ I/PRP ]
guess/VBP 
[ my/PRP$ ego/NN ]
could/MD be/VB hurt/VBN ,/, ''/'' but/CC 
[ it/PRP ]
is/VBZ n't/RB ,/, 
[ he/PRP ]
said/VBD in/IN 
[ a/DT phone/NN interview/NN ]
./. 

``/`` Were/VBD 
[ I/PRP ]
to/TO stay/VB ,/, 
[ there/EX ]
would/MD n't/RB be/VB very/RB much/JJ to/TO do/VB ./. 

''/'' 
======================================

At/IN 
[ Information/NNP Resources/NNP Mr./NNP Andress/NNP ]
,/, 
[ 50/CD years/NNS ]
old/JJ ,/, will/MD move/VB into/IN 
[ a/DT spot/NN ]
left/VBN 
[ vacant/JJ ]
by/IN 
[ Gian/NNP Fulgoni/NNP ]
,/, 
[ who/WP ]
moved/VBD up/RB 
[ last/JJ January/NNP ]
to/TO become/VB 
[ the/DT company/NN 's/POS chief/JJ executive/JJ officer/NN ]
./. 

======================================

[ Drug-industry/JJ analysts/NNS ]
were/VBD surprised/VBN and/CC dismayed/VBN by/IN 
[ his/PRP$ sudden/JJ departure/NN ]
./. 

[ Erling/NNP Refsum/NNP ]
,/, 
[ a/DT drug/NN analyst/NN ]
at/IN 
[ Nomura/NNP Research/NNP Institute/NNP ]
in/IN 
[ London/NNP ]
,/, said/VBD ,/, ``/`` 
[ It/PRP ]
's/VBZ 
[ part/NN ]
of/IN 
[ a/DT shakeout/NN ]
,/, obviously/RB ./. 

''/'' 
======================================

[ Mr./NNP Andress/NNP ]
was/VBD highly/RB regarded/VBN for/IN 
[ his/PRP$ leadership/NN ]
of/IN 
[ Beecham/NNP 's/POS pharmaceuticals/NNS business/NN ]
./. 

[ One/CD ex-Beecham/JJ executive/NN ]
suggested/VBD 
[ Mr./NNP Andress/NNP ]
may/MD be/VB quitting/VBG because/IN 
[ Mr./NNP Chappell/NNP ]
edged/VBD 
[ him/PRP ]
out/RB ./. 

======================================

But/CC 
[ Mr./NNP Andress/NNP ]
,/, 
[ who/WP ]
helped/VBD arrange/VB 
[ the/DT SmithKline/NNP deal/NN ]
and/CC has/VBZ been/VBN 
[ a/DT board/NN member/NN ]
of/IN 
[ the/DT merged/VBN company/NN ]
,/, recalled/VBD that/IN 
[ he/PRP ]
did/VBD n't/RB 
[ object/VB ]
to/TO 
[ Mr./NNP Chappell/NNP 's/POS appointment/NN ]
./. 

``/`` 
[ It/PRP ]
seemed/VBD to/TO make/VB 
[ sense/NN ]
that/IN 
[ John/NNP ]
be/VB in/IN 
[ charge/NN ]
of/IN integrating/VBG 
[ the/DT much/RB larger/JJR SmithKline/NNP ]
 {/( 
[ pharmaceuticals/NNS ]
 }/) 
[ business/NN ]
with/IN 
[ the/DT smaller/JJR Beecham/NNP business/NN ]
,/, ''/'' 
[ he/PRP ]
said/VBD ./. 

======================================

[ Mr./NNP Andress/NNP ]
added/VBD that/IN 
[ personal/JJ reasons/NNS ]
also/RB influenced/VBN 
[ his/PRP$ return/NN ]
to/TO 
[ Chicago/NNP ]
,/, where/WRB 
[ his/PRP$ wife/NN ]
and/CC 
[ three/CD children/NNS ]
live/VBP ./. 

[ His/PRP$ family/NN ]
never/RB moved/VBD when/WRB 
[ he/PRP ]
left/VBD 
[ Abbott/NNP ]
in/IN 
[ 1984/CD ]
to/TO join/VB 
[ Sterling/NNP Drug/NNP ]
./. 

======================================

[ Analysts/NNS ]
nevertheless/RB see/VBP 
[ the/DT resignation/NN ]
as/IN 
[ an/DT indication/NN ]
of/IN 
[ SmithKline/NNP Beecham/NNP 's/POS difficulties/NNS ]
in/IN quickly/RB delivering/VBG 
[ the/DT merger/NN ]
's/POS promised/VBN ``/`` 
[ synergy/NN ]
./. 

''/'' 
[ Many/JJ investors/NNS ]
foresaw/VBD 
[ gains/NNS ]
from/IN joining/VBG 
[ sales/NNS forces/NNS ]
and/CC possibly/RB 
[ $/$ 600/CD million/CD ]
in/IN 
[ savings/NNS ]
from/IN pruning/VBG 
[ duplicative/JJ functions/NNS ]
./. 

======================================

But/CC combining/VBG 
[ the/DT companies/NNS '/POS far-flung/JJ operations/NNS ]
is/VBZ turning/VBG out/RP to/TO be/VB 
[ a/DT delicate/JJ ]
and/CC 
[ time-consuming/JJ task/NN ]
--/: even/RB though/IN 
[ wholesale/JJ staff/NN cuts/NNS ]
and/CC 
[ plant/NN closings/NNS ]
have/VBP yet/RB to/TO begin/VB ./. 

[ Mr./NNP Bauman/NNP ]
,/, 
[ chief/JJ executive/JJ officer/NN ]
,/, has/VBZ asked/VBN 
[ staff/NN task/NN forces/NNS ]
and/CC 
[ management/NN consultants/NNS McKinsey/NNP Co./NNP ]
to/TO devise/VB restructuring/NN 
[ plans/NNS ]
by/IN 
[ year/NN end/NN ]
./. 

Meanwhile/RB ,/, ``/`` 
[ nobody/NN ]
knows/VBZ 
[ what/WP ]

[ they/PRP ]
are/VBP doing/VBG or/CC for/IN how/WRB long/JJ and/CC why/WRB ,/, ''/'' 
[ a/DT ]
recently/RB retired/VBN 
[ employee/NN ]
said/VBD ./. 

And/CC 
[ few/JJ combined/VBN marketing/NN efforts/NNS ]
have/VBP begun/VBN yet/RB ./. 

======================================

[ There/EX ]
have/VBP been/VBN 
[ other/JJ resignations/NNS ]
among/IN 
[ lower-level/JJ managers/NNS ]
,/, but/CC 
[ Mr./NNP Andress/NNP ]
becomes/VBZ only/RB 
[ the/DT second/JJ top/JJ Beecham/NNP executive/NN ]
to/TO leave/VB since/IN 
[ the/DT merger/NN ]
./. 

[ R./NNP Paul/NNP Tatman/NNP ]
,/, 
[ 55/CD ]
,/, will/MD take/VB 
[ early/JJ retirement/NN ]

[ this/DT month/NN ]
,/, 
[ a/DT spokeswoman/NN ]
said/VBD ./. 

[ He/PRP ]
had/VBD been/VBN 
[ deputy/JJ chairman/NN ]
of/IN 
[ the/DT pharmaceuticals/NNS business/NN ]
and/CC ,/, previously/RB ,/, 
[ a/DT Beecham/NNP board/NN member/NN ]
./. 
